Market Value1,231,704,000
Total Holdings70
File Date2019-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SRPT / Sarepta Therapeutics, Inc.
TSRO / TESARO, Inc. Call
TSRO / TESARO, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
US62857M1053 / MyoKardia, Inc.
NKTR / Nektar Therapeutics
NKTR / Nektar Therapeutics Call
DRNA / Dicerna Pharmaceuticals Inc
ITRM / Iterum Therapeutics plc
NERV / Minerva Neurosciences, Inc.
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
ZGNX / Zogenix Inc
ZGNX / Zogenix Inc Call
ARQL / ArQule, Inc.
QTRX / Quanterix Corporation
ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
US00972L1070 / Akcea Therapeutics Inc. Put
KURA / Kura Oncology, Inc.
RARX / Ra Pharmaceuticals, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
BOLD / Boundless Bio, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
TRIL / Trillium Therapeutics Inc
GTHX / G1 Therapeutics, Inc.
SPPI / Spectrum Pharmaceuticals, Inc.
QTNT / Quotient Ltd
ABEO / Abeona Therapeutics Inc.
TBIO / Telesis Bio, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
INSP / Inspire Medical Systems, Inc.
SAGE / Sage Therapeutics, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
ARNA / Arena Pharmaceuticals Inc
INCY / Incyte Corporation
US74257L1089 / Principia Biopharma Inc.
TCDA / Tricida Inc
BPMC / Blueprint Medicines Corporation
KZR / Kezar Life Sciences, Inc.
CFRX / ContraFect Corp
IFRX / InflaRx N.V.
TWST / Twist Bioscience Corporation
MGTX / MeiraGTx Holdings plc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RUBY / Rubius Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc. Put
AVRO / AVROBIO, Inc.
CLSD / Clearside Biomedical, Inc.
CRSP / CRISPR Therapeutics AG
TBPH / Theravance Biopharma, Inc.
COLL / Collegium Pharmaceutical, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
/ Array BioPharma, Inc.
OMER / Omeros Corporation
OTLK / Outlook Therapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
SLDB / Solid Biosciences Inc.
ALLK / Allakos Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
XLRN / Acceleron Pharma Inc
HRTX / Heron Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
XFOR / X4 Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
SRRK / Scholar Rock Holding Corporation
REPL / Replimune Group, Inc.
AXNX / Axonics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
CTMX / CytomX Therapeutics, Inc.
OMER / Omeros Corporation Call
ANAB / AnaptysBio, Inc.
BHVN / Biohaven Ltd.
APLS / Apellis Pharmaceuticals, Inc.
YMAB / Y-mAbs Therapeutics, Inc.